Elsevier Launches New Journal: International Journal of Paleopathology

Published on Tuesday, 31 May 2011 13:42 Written by TradersHuddle Staff

OXFORD, England, May 31, 2011 /PRNewswire-FirstCall/ --

- A Dedicated Journal for Collaborations and Cutting-Edge Research in Paleopathology - Human and Non-Human

Elsevier, a world-leading publisher of scientific, technical and medical information products and solutions, is pleased to announce the launch of a new journal, International Journal of Paleopathology, the official journal of the Paleopathology Association (http://www.paleopathology.org/). Published quarterly, the first issue of the journal is now freely available to view online on SciVerse ScienceDirect ( http://www.sciencedirect.com/science/journal/18799817). Print copies of the first issue will be available at the 7th World Congress on Mummy Studies (http://associations.sou.edu/aaaspd/2011SANDIEGO/index.html) on 12-16 June 2011 in San Diego, USA, where Elsevier will host a reception to officially launch the journal.

Editor-in-Chief Professor Jane E. Buikstra of Arizona State University said, "I am energized by the challenge of creating an academic journal format that seeks to encourage research and foster interdisciplinary communication. As the only dedicated paleopathology journal in the community, we are extremely proud to have the designation of "Official Journal of the Paleopathology Association".

The International Journal of Paleopathology will publish original and significant articles on human and animal (including hominids) disease. The articles are based on the study of physical remains, including osseous, dental, and preserved soft tissues at a range of methodological levels, from direct observation to molecular, chemical, histological and radiographic analysis. Discussion of ways in which these methods can be applied to the reconstruction of health, disease and life histories in the past is central to the discipline. This way the journal would also encourage papers covering interpretive and theoretical issues, and those that place the study of disease at the centre of a bioarchaeological or biocultural approach.

Papers dealing with historical evidence relating to disease in the past - rather than with history of medicine - will also be published. The journal will also accept significant studies that apply previously developed techniques to new materials, setting the research in the context of current debates on past human and animal health. Paper types encouraged are original research articles, case studies, technical notes, brief communications, book reviews and invited commentaries.

The first issue of the International Journal of Paleopathology is now freely available to view online on SciVerse ScienceDirect ( http://www.sciencedirect.com/science/journal/18799817), as well as the first issue's Welcome Editorial from the Editor-in-Chief, Jane E. Buikstra.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com) and Cell (http://www.cell.com ), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect (http://www.sciencedirect.com), SciVerse Scopus ( http://www.scopus.com), Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and Nursing Consult (http://www.nursingconsult.com ), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( http://www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media contact

    Lyndsay Scholefield
    +44-1865-843825
    
 This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
 

SOURCE Elsevier